Missed Red Flags in Rheumatic Care

Fatigue and frailty, two common comorbidities of inflammatory rheumatic diseases, often receive insufficient attention in rheumatologic care settings. Fatigue significantly reduces quality of life, while frailty is associated with numerous risks and is not limited to older adults, according to Klaus Krüger, MD, head of the St. Bonifatius Rheumatology Practice Center in Munich, Germany. Speaking … Read more

Gender gaps in peripheral vascular disease impact diagnosis and treatment

The disparities between men and women in prevalence, risk factors and symptoms of peripheral vascular disease (PVD) have a profound impact on prevention, diagnosis, treatment and outcomes for women, according to a new American Heart Association scientific statement published today in the Association’s flagship, peer-reviewed journal Circulation. “Peripheral vascular disease is often under-recognized and understudied in women,” … Read more

Vasculitis Patients Need Multiple COVID Vaccine Boosters

People with vasculitis may need at least three or four vaccinations for COVID-19 before they start to show an immune response against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, new research has suggested. In a longitudinal retrospective study, serum antibody neutralization against the Omicron variant of the virus and its descendants was found to … Read more

Cancer Immunotherapy May Raise Rheumatoid Arthritis Risk

TOPLINE: According to a study of over five million patients with a neoplasm, those who received an immune checkpoint inhibitor (ICI) faced a 26% higher risk for rheumatoid arthritis (RA) than those receiving other types of cancer therapy. METHODOLOGY: Researchers conducted this retrospective observational study using data from the global federated research network TriNetX to … Read more

Immunocompromised individuals need regular boosters for Covid-19 protection

Vaccinations alone may not be enough to protect people with compromised immune systems from infection, even if the vaccine has generated the production of antibodies, new research from the University of Cambridge has shown. The findings, published today in Science Advances, suggest that such individuals will need regular vaccine boosters to protect them and reduce … Read more

Cambridge Study Reveals Vaccinations May Not Fully Protect Immunocompromised Patients

I understand. Here are a few ways to ensure that your article focuses on the needs and challenges of immunocompromised individuals regarding COVID-19 vaccines: Highlight the unique risks: Clearly explain that immunocompromised individuals face a higher risk of severe illness, hospitalization, and death from COVID-19, even after vaccination. Emphasize the importance of booster shots: Underscore … Read more

Baricitinib Shows Promise in Polymyalgia Rheumatica

Baricitinib can effectively treat polymyalgia rheumatica (PMR) without the use of oral glucocorticoids, according to results from a small, randomized, double-blind, placebo-controlled study. Among the 18 patients randomly assigned to the oral Janus kinase (JAK) inhibitor baricitinib, 14 achieved a C-reactive protein PMR activity score (CRP PMR-AS) of 10 or less after 12 weeks of … Read more